AU8025998A - Biologically active materials - Google Patents

Biologically active materials

Info

Publication number
AU8025998A
AU8025998A AU80259/98A AU8025998A AU8025998A AU 8025998 A AU8025998 A AU 8025998A AU 80259/98 A AU80259/98 A AU 80259/98A AU 8025998 A AU8025998 A AU 8025998A AU 8025998 A AU8025998 A AU 8025998A
Authority
AU
Australia
Prior art keywords
drug
biologically active
active materials
polymer
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU80259/98A
Other languages
English (en)
Inventor
James Cassidy
Ruth Duncan
Lisa German
Dale Hirst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovata Ltd
Original Assignee
ML Laboratories PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712100.8A external-priority patent/GB9712100D0/en
Application filed by ML Laboratories PLC filed Critical ML Laboratories PLC
Publication of AU8025998A publication Critical patent/AU8025998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU80259/98A 1997-06-12 1998-06-12 Biologically active materials Abandoned AU8025998A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9712100.8A GB9712100D0 (en) 1997-06-12 1997-06-12 Biologically active materials
GB9712100 1997-06-12
US5427797P 1997-07-30 1997-07-30
US60054277 1997-07-30
PCT/GB1998/001567 WO1998056424A1 (en) 1997-06-12 1998-06-12 Biologically active materials

Publications (1)

Publication Number Publication Date
AU8025998A true AU8025998A (en) 1998-12-30

Family

ID=26311695

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80259/98A Abandoned AU8025998A (en) 1997-06-12 1998-06-12 Biologically active materials

Country Status (7)

Country Link
US (1) US6338843B1 (https=)
EP (1) EP0998303B1 (https=)
JP (1) JP2002508758A (https=)
AT (1) ATE317703T1 (https=)
AU (1) AU8025998A (https=)
DE (1) DE69833487T9 (https=)
WO (1) WO1998056424A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1191093C (zh) * 1998-10-30 2005-03-02 第一制药株式会社 Dds化合物及其测定方法
EP1198253A2 (en) * 1999-06-18 2002-04-24 ML Laboratories Plc Biologically active materials
EP1296719A2 (en) * 2000-07-01 2003-04-02 ML Laboratories Plc Dextrin - amphotericin conjugates and their methods of preparation
DE60131177T2 (de) * 2000-09-06 2008-08-07 AP Pharma, Inc., Redwood Abbaubare polyacetal-polymere
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
DE10129369C1 (de) 2001-06-21 2003-03-06 Fresenius Kabi De Gmbh Wasserlösliches, einen Aminozucker aufweisendes Antibiotikum in Form eines Pol ysaccharid-Konjugats
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
ITMI20020681A1 (it) * 2002-03-29 2003-09-29 Acs Dobfar Spa Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina
US7538092B2 (en) 2002-10-08 2009-05-26 Fresenius Kabi Deutschland Gmbh Pharmaceutically active oligosaccharide conjugates
WO2004081538A2 (en) 2003-03-13 2004-09-23 Irm, Llc Compositions and methods of vinyl oxazolone polymerization
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
EP1734819A1 (en) * 2004-03-19 2006-12-27 Pro-Pharmaceuticals, Inc. Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymers
US11331392B2 (en) 2014-12-04 2022-05-17 The Trustees Of Columbia University In The City Of New York Biodegradable thermo-responsive polymers and uses thereof
GB2551979A (en) 2016-06-30 2018-01-10 Rs Arastirma Egitim Danismanlik Llac Sanayi Ticaret Ltd Cleavable polymer drug conjugates

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1044798B (it) 1974-10-15 1980-04-21 Ferruti Paolo Alti polimeri contenenti acido nicotinico processo per la loro preparazione e loro impiego
JPS5756500A (en) * 1980-09-22 1982-04-05 Otsuka Pharmaceut Co Ltd Novel bufadienolide-type steroid
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US5554386A (en) 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides
US4793986A (en) * 1987-02-25 1988-12-27 Johnson Matthey, Inc. Macromolecular platinum antitumor compounds
GB9020861D0 (en) 1990-09-25 1990-11-07 Ml Lab Plc Pharmaceutical compositions
EP0540751A4 (en) 1991-05-20 1994-10-26 Eisai Co Ltd Steroid compound combined with polysaccharide
GB9217998D0 (en) * 1992-08-24 1992-10-07 Wellcome Found Methods of treating cancer
WO1995005199A1 (en) 1993-08-19 1995-02-23 Dextran Products Limited Pharmaceutical preparation and a process for making same

Also Published As

Publication number Publication date
DE69833487T9 (de) 2007-03-01
DE69833487D1 (de) 2006-04-20
EP0998303A1 (en) 2000-05-10
JP2002508758A (ja) 2002-03-19
US6338843B1 (en) 2002-01-15
ATE317703T1 (de) 2006-03-15
DE69833487T2 (de) 2006-10-12
EP0998303B1 (en) 2006-02-15
WO1998056424A1 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
AU8025998A (en) Biologically active materials
WO2000064486A3 (en) Enzymatically activated polymeric drug conjugates
WO2000041538A3 (en) Dermal compositions
EP1374908A3 (en) Polymer-drug conjugates comprising hydrazide linkers
WO2004110358A3 (en) Polymeric conjugates for tissue activated drug delivery
EP1712228A3 (en) Hyaluronic acid derivatives for the prevention and treatment of cutaneous scars
WO2004060405A3 (en) Tissue reactive compounds and compositions and uses thereof
WO1999036099A8 (fr) Compositions a liberation controlee, leur procede de fabrication et leur utilisation
DE69721481D1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
SI0973819T1 (sl) Neantigenski razvejeni polimerni konjugati
AU3816693A (en) Preparation and use of polyanionic polymer-based conjugates targeted to vascular endothelial cells
IL135148A0 (en) A polysaccharide conjugate and pharmaceutical compositions containing the same
EP0679390A3 (en) Sprayable topical pharmaceutical compositions
AU2001288829A1 (en) Degradable polyacetal polymers
CA2255637A1 (en) Conjugates of cis-docosahexaenoic acid and paclitaxel
AU6357900A (en) Hyaluronic acid-protein conjugates, pharmaceutical compositions and related methods
CA2174325A1 (en) Non-antigenic branched polymer conjugates
ATE356638T1 (de) Hydrolytisch abbaubare carbamatderivate von polyethylenglykol
AU2845599A (en) Pharmaceutical compositions and their use
AU5376500A (en) Functional poly-alpha-aminoacid derivatives useful for the modification of biologically active materials and their application
NZ515999A (en) Biologically active materials
WO2001060412A3 (en) Modification of biopolymers for improved drug delivery
DE69609501D1 (de) Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte
NO20012161D0 (no) Laktonb¶rende absorberbare polymerer
EP0859597A4 (https=)

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase